Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $414.5 million.

  • Agilon Health's Shares Outstanding (Weighted Average) rose 69.83% to $414.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.5 million, marking a year-over-year increase of 69.83%. This contributed to the annual value of $411.0 million for FY2024, which is 50.11% up from last year.
  • Per Agilon Health's latest filing, its Shares Outstanding (Weighted Average) stood at $414.5 million for Q3 2025, which was up 69.83% from $413.8 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Shares Outstanding (Weighted Average) ranged from a high of $414.5 million in Q3 2025 and a low of $325.7 million during Q1 2021
  • For the 5-year period, Agilon Health's Shares Outstanding (Weighted Average) averaged around $401.4 million, with its median value being $411.0 million (2024).
  • Per our database at Business Quant, Agilon Health's Shares Outstanding (Weighted Average) surged by 2343.1% in 2022 and then plummeted by 101.61% in 2024.
  • Over the past 5 years, Agilon Health's Shares Outstanding (Weighted Average) (Quarter) stood at $372.9 million in 2021, then increased by 9.44% to $408.2 million in 2022, then increased by 0.19% to $408.9 million in 2023, then grew by 0.5% to $411.0 million in 2024, then rose by 0.85% to $414.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $414.5 million in Q3 2025, compared to $413.8 million in Q2 2025 and $412.9 million in Q1 2025.